Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 204S204 trades$51.20M
Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
MSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
FFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
ULCCFrontier Group Holdings, Inc.Nov 5 – Nov 117 insiders$1.31M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 14 | Venker EricPresident & Immunovant CEO |  ROIVRoivant Sciences Ltd.Open-market sale · 10b5-1 plan | SELL | $5.08M 153.8K sh | Jun 26, 2026 |
| 14 | Chandhok NikhilChief Product & Tech. Officer | CRCLCircle Internet Group, Inc. Open-market sale · 10b5-1 plan | SELL | $7.93M 112.0K sh | Jun 26, 2026 traded Jun 24, 2026 |
| 14 | Chandhok NikhilChief Product & Tech. Officer | CRCLCircle Internet Group, Inc. Open-market sale · 10b5-1 plan | SELL | $5.27M 73.7K sh | Jun 26, 2026 traded Jun 24, 2026 |
| 13 | Menu PhilippeChief Medical Officer |  SOPHSOPHiA GENETICS SAOpen-market sale · 10b5-1 plan | SELL | $28K 5,000 sh | Jun 26, 2026 traded Jun 25, 2026 |
| 13 | Rubin KevinChief Financial Officer |  ZSZscaler, Inc.Open-market sale · 10b5-1 plan | SELL | $70K 560 sh | Jun 26, 2026 traded Jun 25, 2026 |
| 13 | Rubin KevinChief Financial Officer | ZSZscaler, Inc. Open-market sale · 10b5-1 plan | SELL | $210K 1,696 sh | Jun 26, 2026 traded Jun 25, 2026 |
| 13 | Van Tuyl ChristopherChief Legal Officer |  IMVTImmunovant, Inc.Option exercise | M | — 17.8K sh | Jun 26, 2026 traded Jun 26, 2026 |
| 13 | Hughes AaronDirector |  SSentinelOne, Inc.Grant or award | A | — 4,176 sh | Jun 26, 2026 traded Jun 25, 2026 |
| 13 | Frazier WilliamDirector, Chief Medical Officer |  VMDVIEMED HEALTHCARE, INC.Option exercise | M | $18K 10.0K sh | Jun 26, 2026 traded Jun 25, 2026 |
| 13 | Bohnert Christopher HSVP, Chief Financial Officer |  NNBRNN INCTax withholding | F | $25K 9,205 sh | Jun 26, 2026 traded Jun 25, 2026 |
| 13 | DeSimone JillDirector |  PRAXPraxis Precision Medicines, Inc.Option exercise · 10b5-1 plan | M | $447K 3,034 sh | Jun 26, 2026 traded Jun 24, 2026 |
| 13 | Rubin KevinChief Financial Officer | ZSZscaler, Inc. Open-market sale · 10b5-1 plan | SELL | $62K 504 sh | Jun 26, 2026 traded Jun 25, 2026 |
| 12 | DeSimone JillDirector | PRAXPraxis Precision Medicines, Inc. Open-market sale · 10b5-1 plan | SELL | $158K 504 sh | Jun 26, 2026 traded Jun 24, 2026 |
| 12 | Hancock MarkDirector, Co Fndr; Exec V Chair, 10% Owner |  PACSPACS Group, Inc.Open-market sale · 10b5-1 plan | SELL | $2.50M 61.7K sh | Jun 26, 2026 traded Jun 26, 2026 |
| 12 | Hancock MarkDirector, Co Fndr; Exec V Chair, 10% Owner | PACSPACS Group, Inc. Open-market sale · 10b5-1 plan | SELL | $5.57M 138.1K sh | Jun 26, 2026 traded Jun 25, 2026 |
| 12 | Wierbicki PaulDirector, Chief Legal Officer |  RSIRush Street Interactive, Inc.Option exercise | M | $74K 6,926 sh | Jun 26, 2026 traded Jun 25, 2026 |
| 12 | Burrows Scott LChief Financial Officer |  SYRESpyre Therapeutics, Inc.Option exercise | M | $218K 15.0K sh | Jun 26, 2026 traded Jun 25, 2026 |
| 12 | Leibrock Robert WilliamChief Financial Officer |  ACIWACI WORLDWIDE, INC.Disposition to issuer | D | $114K 2,454 sh | Jun 26, 2026 traded Jun 24, 2026 |
| 12 | DeSimone JillDirector | PRAXPraxis Precision Medicines, Inc. Open-market sale · 10b5-1 plan | SELL | $210K 683 sh | Jun 26, 2026 traded Jun 24, 2026 |
| 12 | Rabinowitz DanielSEC. AND CHIEF LEGAL OFFICER | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $1.28M 5,066 sh | Jun 26, 2026 traded Jun 24, 2026 |
| 12 | Caldwell Jonathan L.Chief People Officer |  VVVVALVOLINE INCOpen-market sale · 10b5-1 plan | SELL | $114K 2,851 sh | Jun 26, 2026 traded Jun 25, 2026 |
| 11 | Islam NayaabSee Remarks |  STUBStubHub Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $302K 25.1K sh | Jun 26, 2026 traded Jun 26, 2026 |
| 11 | Sakamoto Ryan T.EVP, Chief Legal Officer |  ZIPZIPRECRUITER, INC.Open-market sale · 10b5-1 plan | SELL | $11K 2,978 sh | Jun 26, 2026 traded Jun 25, 2026 |
| 11 | Daunt JohnEVP, Chief Commercial Officer |  LQDTLIQUIDITY SERVICES INCOpen-market sale · 10b5-1 plan | SELL | $296K 7,539 sh | Jun 26, 2026 traded Jun 24, 2026 |
| 10 | Rubin KevinChief Financial Officer | ZSZscaler, Inc. Open-market sale · 10b5-1 plan | SELL | $29K 228 sh | Jun 26, 2026 traded Jun 25, 2026 |
| 10 | Venker EricPresident & Immunovant CEO | ROIVRoivant Sciences Ltd. Open-market sale · 10b5-1 plan | SELL | $1.55M 46.2K sh | Jun 26, 2026 traded Jun 24, 2026 |
| 10 | Rubin KevinChief Financial Officer | ZSZscaler, Inc. Open-market sale · 10b5-1 plan | SELL | $1,521 12 sh | Jun 26, 2026 traded Jun 25, 2026 |
| 9 | Hendricks Dana SChief Financial Officer |  PRAPROASSURANCE CORPDisposition to issuer | D | — 7,686 sh | Jun 26, 2026 traded Jun 26, 2026 |
| 9 | Albright Craig MorrowEVP, Chief Financial Officer |  WLYWLYBJOHN WILEY & SONS, INC.Grant or award | A | — 20.0K sh | Jun 26, 2026 traded Jun 25, 2026 |
| 9 | Kelly MichaelDirector |  SPRYARS Pharmaceuticals, Inc.Grant or award | A | — 30.0K sh | Jun 26, 2026 traded Jun 24, 2026 |
| 9 | Shahbazi HamedDirector |  NAGENiagen Bioscience, Inc.Grant or award | A | — 31.7K sh | Jun 26, 2026 traded Jun 24, 2026 |
| 9 | Manko Joseph M. Jr.Director |  MYOMYOMO, INC.Grant or award | A | — 78.7K sh | Jun 26, 2026 traded Jun 25, 2026 |
| 9 | Rabinowitz DanielSEC. AND CHIEF LEGAL OFFICER | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $302K 1,200 sh | Jun 26, 2026 traded Jun 24, 2026 |
| 9 | Hendricks Dana SChief Financial Officer | PRAPROASSURANCE CORP Disposition to issuer | D | — 23.7K sh | Jun 26, 2026 traded Jun 26, 2026 |
| 9 | Burke William P. Mr.Director |  AXGNAxogen, Inc.Grant or award | A | — 4,392 sh | Jun 26, 2026 traded Jun 24, 2026 |
| 9 | Patrick KristinDirector | NAGENiagen Bioscience, Inc. Grant or award | A | — 31.7K sh | Jun 26, 2026 traded Jun 24, 2026 |
| 9 | Silver Deirdre P.EVP, General Counsel | WLYWLYBJOHN WILEY & SONS, INC. Grant or award | A | — 6,443 sh | Jun 26, 2026 traded Jun 25, 2026 |
| 9 | Ignelzi Troy A.Director |  CTNMContineum Therapeutics, Inc.Grant or award | A | — 19.0K sh | Jun 26, 2026 traded Jun 26, 2026 |
| 9 | McMahan DanielleEVP, Chief People Officer | WLYWLYBJOHN WILEY & SONS, INC. Grant or award | A | — 7,987 sh | Jun 26, 2026 traded Jun 25, 2026 |
| 9 | Francis Robert DavidPres Healthcare Pro. Liability | PRAPROASSURANCE CORP Disposition to issuer | D | — 23.7K sh | Jun 26, 2026 traded Jun 26, 2026 |